//
The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study
Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial
A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women
Circadian-Regulated Cell Death in Cardiovascular Diseases
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?
Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analyses